1. Home
  2. CRWS vs BLRX Comparison

CRWS vs BLRX Comparison

Compare CRWS & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRWS
  • BLRX
  • Stock Information
  • Founded
  • CRWS 1957
  • BLRX 2003
  • Country
  • CRWS United States
  • BLRX Israel
  • Employees
  • CRWS N/A
  • BLRX N/A
  • Industry
  • CRWS Textiles
  • BLRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRWS Consumer Discretionary
  • BLRX Health Care
  • Exchange
  • CRWS Nasdaq
  • BLRX Nasdaq
  • Market Cap
  • CRWS 49.2M
  • BLRX 54.1M
  • IPO Year
  • CRWS N/A
  • BLRX 2011
  • Fundamental
  • Price
  • CRWS $4.84
  • BLRX $0.46
  • Analyst Decision
  • CRWS
  • BLRX Strong Buy
  • Analyst Count
  • CRWS 0
  • BLRX 2
  • Target Price
  • CRWS N/A
  • BLRX $11.50
  • AVG Volume (30 Days)
  • CRWS 16.1K
  • BLRX 308.2K
  • Earning Date
  • CRWS 11-13-2024
  • BLRX 11-18-2024
  • Dividend Yield
  • CRWS 6.64%
  • BLRX N/A
  • EPS Growth
  • CRWS N/A
  • BLRX N/A
  • EPS
  • CRWS 0.41
  • BLRX N/A
  • Revenue
  • CRWS $86,721,000.00
  • BLRX $17,048,000.00
  • Revenue This Year
  • CRWS N/A
  • BLRX N/A
  • Revenue Next Year
  • CRWS N/A
  • BLRX N/A
  • P/E Ratio
  • CRWS $11.70
  • BLRX N/A
  • Revenue Growth
  • CRWS 13.41
  • BLRX N/A
  • 52 Week Low
  • CRWS $4.11
  • BLRX $0.43
  • 52 Week High
  • CRWS $5.97
  • BLRX $1.93
  • Technical
  • Relative Strength Index (RSI)
  • CRWS 55.51
  • BLRX 26.70
  • Support Level
  • CRWS $4.76
  • BLRX $0.43
  • Resistance Level
  • CRWS $4.90
  • BLRX $0.56
  • Average True Range (ATR)
  • CRWS 0.06
  • BLRX 0.05
  • MACD
  • CRWS 0.01
  • BLRX -0.01
  • Stochastic Oscillator
  • CRWS 62.60
  • BLRX 12.42

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: